An emergency psychiatric consultation was requested for a 48-year-old man who was admitted to the coronary care unit (CCU) with massive myocardial infarction (MI). He was reported to be acutely agitated, and he wanted to sign out against medical advice. The reason for consultation was to determine the patient’s competence to sign out. When the consultant arrived in the CCU, a number of staff members were surrounding the patient as he attempted to exit the cubicle. He shouted, “I want to get out! You cannot hold me here!”


Irritable Bowel Syndrome Generalize Anxiety Disorder Social Phobia Panic Disorder Posttraumatic Stress Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bremner JD, Randall PR, Capelli S, et al. The neurobiology of posttraumatic stress disorder: an integration of animal and human research. In: Saigh P, Bremner JD, eds. Posttraumatic Stress Disorder: A Comprehensive Text. New York: Allyn & Bacon, 1999:103–143.Google Scholar
  2. Bremner JD, Randall PR, Capelli S, Scott T, McCarthy G, Charney DS. Deficits in short-term memory in adult survivors of childhood abuse. Psych Res 1995a;59:97–107.CrossRefGoogle Scholar
  3. Bremner JD, Randall PR, Scott TM, et al. MRI-based measurement of hippocampal volume in posttraumatic stress disorder. Am J Psychiatry 1995b;152:973–981.PubMedGoogle Scholar
  4. Coetzer BR. Obsessive-compulsive disorder following brain injury: a review. Int J Psychiatry Med 2004;34(4):363–377.PubMedCrossRefGoogle Scholar
  5. Davidson JR. Pharmacotherapy of generalized anxiety disorder. J Clin Psychiatry 2001;62 Suppl 11:46–50.PubMedGoogle Scholar
  6. Gil S, Caspi Y, Zilberman Ben-Ari I, Koren D, Klein E. Does memory of a traumatic event increase the risk for posttraumatic stress disorder in patients with traumatic brain injury? A prospective study. Am J Psychiatry 2005;162:963–969.PubMedCrossRefGoogle Scholar
  7. Lieb R, Becker E, Altamura C. The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol 2005;15(4):445–452.PubMedCrossRefGoogle Scholar
  8. Litz B, Gray M, Bryant R, Adler A. Early intervention for trauma: current status and future directions. A National Center for PTSD Fact Sheet, 2005.Google Scholar
  9. Merikangas KR, Avenevoli S, Acharyya S, Zhang H, Angst J. The spectrum of social phobia in the Zurich cohort study of young adults. Biol Psychiatry 2002;51(1):81–91.PubMedCrossRefGoogle Scholar
  10. Neumeister A, Bain E, Nugent AC, et al. Reduced serotonin type 1a receptor binding in panic disorder. J Neurosci 2004;24(3):589–591.PubMedCrossRefGoogle Scholar
  11. Sapolsky RM. Why stress is bad for your brain. Science 1996;273:749–750.PubMedCrossRefGoogle Scholar
  12. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNA in the hippocampus. J Neurosci 1995;15:1768–1777.PubMedGoogle Scholar
  13. Uno H, Tarara R, Else JG, Suleman MA, Sapolsky RM. Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 1989;9:1705–1711.PubMedGoogle Scholar
  14. Weissman MM, Bland RC, Canino GJ, et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997;54(4):305–309.PubMedGoogle Scholar


  1. Albano AM, Marten PA, Holt CS, Heimberg RG, Barlow DH. Cognitive-behavioral group treatment for social phobia in adolescents. A preliminary study. J Nerv Ment Dis 1995;183(10):649–656.PubMedGoogle Scholar
  2. Beidel DC, Turner SM, Morris TL. Behavioral treatment of childhood social phobia. J Consult Clin Psychol 2000;68(6):1072–1080.PubMedCrossRefGoogle Scholar
  3. Davidson JR, DuPont RL, Hedges D, Haskins JT. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999;60(8):528–535.PubMedGoogle Scholar
  4. Davidson JR, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13(6):423–428.PubMedCrossRefGoogle Scholar
  5. Gorman JM. Treatment of generalized anxiety disorder. J Clin Psychiatry 2002;63(suppl 8):17–23.PubMedGoogle Scholar
  6. Gray MJ, Litz BT. Behavioral interventions for recent trauma: empirically informed practice guidelines. Behav Modif 2005;9(1):189–215.CrossRefGoogle Scholar
  7. Nesse RM. The smoke detector principle natural selection and the regulation of defensive responses. Ann NY Acad Sci 2001;935:75–85.PubMedCrossRefGoogle Scholar
  8. Pollack MH, Zaninelli R, Goddard A, et al. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001;62(5):350–357.PubMedGoogle Scholar
  9. Spence SH, Donovan C, Brechman-Toussaint M. The treatment of childhood social phobia: the effectiveness of a social skills training-based, cognitive-behavioural intervention, with and without parental involvement. J Child Psychol Psychiatry 2000;41:713–726.PubMedCrossRefGoogle Scholar
  10. Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA 1998;280(8):708–713.PubMedCrossRefGoogle Scholar
  11. Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B, Pynoos JD, Zatzick DF, Benedek DM, McIntyre JS, Charles SC, Altshuler K, Cook I, Cross CD, Mellman L, Moench LA, Norquist G, Twemlow SW, Woods S, Yager J. Work Group on ASD and PTSD; Steering Committee on Practice stress disorder and posttraumatic stress disorder. Am J Psychiatry 2004 Nov;161(11 Suppl):3–31.PubMedGoogle Scholar
  12. van Vliet IM, den Boer JA, Westenberg HG. Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 1994;115(1–2):128–134.CrossRefGoogle Scholar
  13. Zai G, Arnold P, Burroughs E, Barr CL, Richter MA, Kennedy JL. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2005;134(1):25–29.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Hoyle Leigh
    • 1
  1. 1.University of CaliforniaFresnoUSA

Personalised recommendations